Cookie Preference

This website uses cookies to improve user experience. Please select an option.  Privacy Policy

No cookies except for those necessary for technical reasons are set.


Ascenion is partner of ITN consortium ‘SMABEYOND’ on spinal muscular atrophy research

Ascenion will support eight members and four partners of the Innovative Training Network (ITN) ‘SMABEYOND’ in all aspects relating to the intellectual property and potential commercialization of their work.

The ITN, led by Hannover Medical School (MHH), pursues an inter-sectoral approach to develop novel strategies for treating spinal muscular atrophy (SMA), a rare neurodegenerative disease with a significant unmet medical need.

Ascenion will provide training to raise the researchers’ awareness for the commercial and societal impact of their work. The technology managers and legal experts will also be available to consult the consortium on IP-relevant questions or issues that may arise throughout their collaboration.

The SMABEYOND network is funded by the European Union for four years with a total of EUR 2.14 million under the Horizon 2020 program.

For further information on the scientific focus of SMABEYOND see the MHH’s press release (available in German only).